Gary A Ulaner (Gary Ulaner)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Endoplasmic Reticulum

Positron Emission Tomography

Top Venues

European journal of nuclear medicine and molecular imaging

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Gary A Ulaner
HER2-targeted PET for Patients with Breast Cancer: Scintillating Data. Radiology 311 (3) (2024)
Gary A Ulaner, Louis A VanderMolen, Gary Li, Denis Ferreira
Dotatate PET/CT and 225 Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer. Radiology 312 (1) (2024)
Gary A Ulaner
HER2-targeted PET for Patients with Breast Cancer: Scintillating Data. Radiology 311 (3) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging (2024)
Gary A Ulaner, Louis A VanderMolen, Gary Li, Denis Ferreira
Dotatate PET/CT and 225 Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer. Radiology 312 (1) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Ashley Elimar Aaroe, Razelle Kurzrock, Gaurav Goyal, Aaron Michael Goodman, Harsh Patel, Gordon J Ruan, Gary A Ulaner, Jason R Young, Ziyi Li, Derek Dustin, Ronald S Go, Eli L Diamond, Filip Janku
Successful Treatment of Non-Langerhans Cell Histiocytosis with the MEK Inhibitor Trametinib: A Multicenter Analysis. Blood advances (2023)
Ping Chi, Li-Xuan Qin, Bastien Nguyen, Ciara M Kelly, Sandra P D' Angelo, Mark A Dickson, Mrinal M Gounder, Mary L Keohan, Sujana Movva, Benjamin A Nacev, Evan Rosenbaum, Katherine A Thornton, Aimee M Crago, Sam Yoon, Gary A Ulaner, Randy Yeh, Moriah Martindale, Haley T Phelan, Matthew D Biniakewitz, Sarah Warda, Cindy J Lee, Michael F Berger, Samuel Singer, Sinchun Hwang, Yu Chen, Cristina R Antonescu, William D Tap
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Gary A Ulaner, Beth Thomsen, Jeffrey Bassett, Robert Torrey, Craig Cox, Kevin Lin, Trushar Patel, Tust Techasith, Audrey Mauguen, Steven P Rowe, Liza Lindenberg, Esther Mena, Peter C Black, Jeffrey Yoshida
18 F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Radiology 305 (2) (2022)
Julian Kirchner, Joseph A O'Donoghue, Anton S Becker, Gary A Ulaner
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm. EJNMMI physics 8 (1) (2021)
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, Assen S Kirov, Christopher C Riedl, Ryan Min, Eric Smith, Lukas Michael Carter, Serge K Lyashchenko, Jason S Lewis, Carl Ola Landgren
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology 295 (3) (2020)
Gary A Ulaner
The QIBA Profile for FDG PET/CT: Improving the Value of PET. Radiology 294 (3) (2020)
Gary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, Randy Yeh, Vaios Hatzoglou, Dara S Ross, Komal Jhaveri, Sarat Chandarlapaty, David M Hyman, Brian M Zeglis, Serge K Lyashchenko, Jason S Lewis
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT. Radiology 296 (2) (2020)
Gary A Ulaner, Raychel Castillo, Jonathan Wills, Mithat Gönen, Debra A Goldman
18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. European journal of nuclear medicine and molecular imaging 44 (9) (2017)